Adare Pharma Solutions: Lombardy as a Strategic Location for Internationalisation and Growth in the Life Sciences Sector

Lombardy continues to strengthen its position as a strategic destination for international companies investing in innovation, research, and industrial development, reinforcing its role among Europe’s leading ecosystems for the life sciences sector.

This was the key message emerging from the video interview produced by Il Sole 24 Ore Radiocor with Adare Pharma Solutions representative Armando Pedoto, focused on the strategic value of Lombardy for the company’s internationalisation and growth processes.

With operational sites in the Milan area, Adare Pharma Solutions represents a concrete example of a high value-added international investment within a territory characterised by specialised expertise, advanced infrastructure, innovation capabilities, and strong integration with global markets.

Lombardy continues to stand out as one of Europe’s leading hubs for the pharmaceutical and life sciences industries, thanks to the presence of excellent production supply chains, research centres, universities, and a business ecosystem that supports the development of innovative and technology-driven activities.

The experiences shared by companies operating in the region confirm the importance of a competitive environment capable of supporting international growth paths, facilitating access to qualified talent, strategic industrial networks, and collaboration opportunities between businesses, research institutions, and public stakeholders.

Within this framework, Invest in Lombardy continues to support foreign investors through dedicated services for business establishment and the development of new entrepreneurial projects across the region, assisting companies throughout every stage of the investment journey.

🎥 Watch the full video:
“Pedoto (Adare Pharma Solutions): Lombardy Strategic for Internationalisation”